{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:18:30Z","timestamp":1783106310583,"version":"3.54.6"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373826"],"award-info":[{"award-number":["82373826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ50138"],"award-info":[{"award-number":["2023JJ50138"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ70120"],"award-info":[{"award-number":["2026JJ70120"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40381"],"award-info":[{"award-number":["2022JJ40381"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["2021SK2036"],"award-info":[{"award-number":["2021SK2036"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["2023SK2043"],"award-info":[{"award-number":["2023SK2043"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioadv.2026.214967","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:22:35Z","timestamp":1779376955000},"page":"214967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancer"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhen","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Qiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Shi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Yun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.214967_bb0005","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic Cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Daniel","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2026.214967_bb0010","first-page":"4200","article-title":"Adjuvant nab-paclitaxel + gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial","volume":"40","author":"Margaret","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0015","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jtho.2021.03.027","article-title":"Phase 3 trial comparing nanoparticle albumin-bound paclitaxel with docetaxel for previously treated advanced NSCLC","volume":"16","author":"Yasuto","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123856","article-title":"Flexoelectricity-boosted core-shell nanoparticles with self-amplified Fenton-like activity for tumor piezocatalytic immunotherapy","volume":"328","author":"Chen","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0025","article-title":"GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs","volume":"15","author":"Qing","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0030","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1134\/S106816202405011X","article-title":"Advances in drug delivery Systems for Lipophilic Drug Paclitaxel: developments, challenges, and opportunities","volume":"50","author":"Kumar","year":"2024","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioadv.2026.214967_bb0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/pharmaceutics14040728","article-title":"Emerging albumin-binding anticancer drugs for tumor-targeted drug delivery: current understandings and clinical translation","volume":"14","author":"Cho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.214967_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biomaterials.2018.06.002","article-title":"Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy","volume":"183","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0045","first-page":"2373","article-title":"STING enhances cell death through regulation of reactive oxygen species and DNA damage","volume":"12","author":"Thomas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214967_bb0050","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3390\/cancers13112670","article-title":"\u201cIt\u2019s always been a second class Cancer\u201d: an exploration of the experiences and journeys of bereaved family Carers of people with sarcoma","volume":"13","author":"O\u2019Connor","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioadv.2026.214967_bb0055","article-title":"A comparative in vivo study of albumin-coated paclitaxel nanocrystals and Abraxane","volume":"14","author":"Joonyoung","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214967_bb0060","first-page":"11","article-title":"Nab-paclitaxel in the treatment of gastrointestinal cancers\u2014improvements in clinical efficacy and safety","volume":"2023","author":"Md","year":"1984","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioadv.2026.214967_bb0065","first-page":"473","article-title":"A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a gynecologic oncology group study","volume":"121","author":"Robert","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semcancer.2019.12.022","article-title":"Ebtesam Abdullah Al-Suhaimi, nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: prospects for the therapeutic management of breast cancer","volume":"69","author":"Mohammad","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","article-title":"Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy","volume":"102","author":"Xiao","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0080","first-page":"267","article-title":"Distinct cellular mechanisms of chemotherapy combined with PD-L1 blockade in triple-negative breast cancer","volume":"43","author":"Yuan","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioadv.2026.214967_bb0085","doi-asserted-by":"crossref","first-page":"19736","DOI":"10.1021\/acsami.1c03065","article-title":"Evidence for delivery of Abraxane via a denatured-albumin transport system","volume":"13","author":"Hama","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2026.214967_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001098","article-title":"Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study","volume":"8","author":"Drusbosky","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioadv.2026.214967_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101458","article-title":"Hyperbaric oxygen regulates tumor mechanics and augments Abraxane and gemcitabine antitumor effects against pancreatic ductal adenocarcinoma by inhibiting cancer-associated fibroblasts","volume":"44","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2026.214967_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2016.06.018","article-title":"Acoustic cluster therapy (ACT) enhances the therapeutic efficacy of paclitaxel and Abraxane\u00ae for treatment of human prostate adenocarcinoma in mice","volume":"236","author":"Van Wamel","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0105","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1038\/ncomms8939","article-title":"A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models","volume":"6","author":"Bhattacharyya","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214967_bb0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2025.01.035","article-title":"Albumin-based delivery systems: recent advances, challenges, and opportunities","volume":"380","author":"Murphy","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201804191","article-title":"Neoadjuvant chemotherapy based on Abraxane\/human neutrophils Cytopharmaceuticals with radiotherapy for gastric Cancer","volume":"15","author":"Ju","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214967_bb0120","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/C5CS00158G","article-title":"Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy","volume":"45","author":"Liu","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioadv.2026.214967_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0130","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.7150\/thno.45391","article-title":"Nanomicelle protects the immune activation effects of paclitaxel and sensitizes tumors to anti-PD-1 immunotherapy","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioadv.2026.214967_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102710","article-title":"pH-responsive nanocomplex for active transport of aPD-1 and PTX to enhance cancer chemoimmunotherapy","volume":"62","author":"Qin","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2026.214967_bb0140","doi-asserted-by":"crossref","first-page":"18963","DOI":"10.1021\/acsnano.4c02312","article-title":"Injectable nanocomposite hydrogels improve intraperitoneal co-delivery of chemotherapeutics and immune checkpoint inhibitors for enhanced peritoneal metastasis therapy","volume":"18","author":"Liang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214967_bb0145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0150","doi-asserted-by":"crossref","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","article-title":"Celecoxib augments paclitaxel-induced immunogenic cell death in triple-negative breast Cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214967_bb0155","doi-asserted-by":"crossref","first-page":"A03","DOI":"10.1158\/2326-6074.TUMIMM18-A03","article-title":"Abstract A03: relieving immune suppressive pathways in breast cancer to improve outcomes","volume":"8","author":"Poissonnier","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bioadv.2026.214967_bb0160","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.2147\/IJN.S418100","article-title":"Co-delivery Nanomicelles for potentiating TNBC immunotherapy by Synergetically reshaping CAFs-mediated tumor stroma and reprogramming immunosuppressive microenvironment","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2026.214967_bb0165","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djab004","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast Cancer: biomarker evaluation of the IMpassion130 study","volume":"113","author":"Emens","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioadv.2026.214967_bb0170","article-title":"Polysaccharide-based stimulus-responsive nanomedicines for combination cancer immunotherapy","volume":"19","author":"Li","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214967_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208546","article-title":"DNA nanoclusters combined with one-shot radiotherapy augments cancer immunotherapy efficiency","volume":"35","author":"Xie","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.214967_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122472","article-title":"Circulating immunotherapy strategy based on pyroptosis and STING pathway: Mn-loaded paclitaxel prodrug nanoplatform against tumor progression and metastasis","volume":"306","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2026.214967_bb0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s44222-023-00099-5","article-title":"Targeted delivery of anti-tumour STING agonist","volume":"1","author":"Ibrahim","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.bioadv.2026.214967_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2024.05.042","article-title":"A next-generation STING agonist MSA-2: from mechanism to application","volume":"371","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bioadv.2026.214967_bb0210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.214967_bb0220","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acs.accounts.3c00309","article-title":"Exploiting albumin as a versatile carrier for Cancer Theranostics","volume":"56","author":"Tao","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioadv.2026.214967_bb0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2014.03.013","article-title":"A clinical update of using albumin as a drug vehicle - a commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214967_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129070","article-title":"Design strategies for enhancing antitumor efficacy through tumor microenvironment exploitation using albumin-based Nanosystems: a review","volume":"258","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0235","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state \u2014 implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioadv.2026.214967_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2026.214967_bb0250","first-page":"1734","article-title":"A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioadv.2026.214967_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201703670","article-title":"A comparative in vivo study of albumin-coated paclitaxel nanocrystals and Abraxane","volume":"14","author":"Park","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2026.214967_bb0260","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acs.nanolett.2c04976","article-title":"Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs","volume":"23","author":"Yang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214967_bb0265","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1016\/j.biomaterials.2013.07.037","article-title":"Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0270","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.actbio.2025.01.038","article-title":"Facile integration of a binary nano-prodrug with \u03b1PD-L1 as a translatable technology for potent immunotherapy of TNBC","volume":"194","author":"Zhou","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2026.214967_bb0275","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2326-6066.CIR-17-0229","article-title":"Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast cancer","volume":"5","author":"Gebremeskel","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bioadv.2026.214967_bb0280","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1038\/s41467-019-11730-8","article-title":"Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence","volume":"10","author":"Song","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214967_bb0285","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/s41467-021-22407-6","article-title":"Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214967_bb0290","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12951-024-03027-w","article-title":"A minimalist multifunctional nano-prodrug for drug resistance reverse and integration with PD-L1 mAb for enhanced immunotherapy of hepatocellular carcinoma","volume":"22","author":"Zou","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0295","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioadv.2026.214967_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122745","article-title":"Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo\u2212\/immuno-therapy for cancer treatments","volume":"312","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214967_bb0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0310","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bioadv.2026.214967_bb0315","first-page":"92","article-title":"Peptide-based targeting of immunosuppressive cells in cancer","volume":"5","author":"Trac","year":"2020","journal-title":"Bioact. Mater."},{"issue":"1814\u20131814","key":"10.1016\/j.bioadv.2026.214967_bb0320","article-title":"Advances in cancer immunotherapies","volume":"186","author":"Dagher","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioadv.2026.214967_bb0325","first-page":"H246","article-title":"gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis","volume":"262","author":"Schnitzer","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bioadv.2026.214967_bb0330","first-page":"4048","article-title":"Evidence for delivery of Abraxane via a denatured-albumin transport system","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioadv.2026.214967_bb0335","first-page":"1377","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Shi","year":"2021","journal-title":"ACS Mol. Pharm."},{"key":"10.1016\/j.bioadv.2026.214967_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1329636","article-title":"GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs","volume":"15","author":"Ji","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214967_bb0345","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1021\/jacs.3c13224","article-title":"Augmenting Cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium (II) Metallacycle","volume":"146","author":"Tu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2026.214967_bb0350","article-title":"A self-reporting fluorescent Salicylaldehyde\u2013Chlorambucil conjugate as a Type-II ICD inducer for cancer vaccines","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.214967_bb0355","article-title":"A self-adaptive rhodium(I) complex-based Nanoplatform with type II immunogenic cell death for near-infrared phosphorescence imaging and Cancer immunotherapy","volume":"14","author":"Wang","year":"2025","journal-title":"Adv. Healthc. Mater."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:46:34Z","timestamp":1783104394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826002657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":71,"alternative-id":["S2772950826002657"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214967","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214967"}}